Literature DB >> 11145614

Dietary phosphorus restriction reverses the impaired bone mineralization in vitamin D receptor knockout mice.

R Masuyama1, Y Nakaya, S Tanaka, H Tsurukami, T Nakamura, S Watanabe, T Yoshizawa, S Kato, K Suzuki.   

Abstract

Deficiency of vitamin D, which is required for calcium homeostasis, causes rickets with hypocalcemia and hypophosphatemia, resulting in growth retardation and impaired bone formation. Mice lacking the vitamin D receptor (VDR) develop the typical features of rickets, establishing that VDR plays a role in controlling the actions of vitamin D. Normalization of impaired mineral homeostasis in VDR KO mice fed a diet supplemented with high concentrations of calcium (2%) and phosphorus (1.25%) is reported to reverse the malformation of bone and the growth retardation as well. However, the relationship between mobilization of phosphorus and calcium and nuclear control of vitamin D actions remains unclear. The present study was undertaken to determine the effect of dietary phosphorus on mineral mobilization and bone mineralization. We report here that feeding a diet supplemented with a restricted amount of phosphorus (0.25%) and a normal amount of calcium (0.5%) for 4 weeks reverses the growth retardation and the impaired mineralization in VDR KO mice, as does a high-calcium and high-phosphorus diet (Ca: 2%; P: 1.25%). Thus, the present study suggests that mobilization of calcium and mobilization of phosphorus are differentially regulated through vitamin D-dependent and -independent systems, and that intake of calcium and phosphorus in the proper ratio is important for mineral homeostasis and bone mineralization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145614     DOI: 10.1210/endo.142.1.8050

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

Review 1.  Minireview: nuclear receptor regulation of osteoclast and bone remodeling.

Authors:  Zixue Jin; Xiaoxiao Li; Yihong Wan
Journal:  Mol Endocrinol       Date:  2014-12-30

2.  Vitamin D endocrine system and the intestine.

Authors:  Sylvia Christakos; Liesbet Lieben; Ritsuko Masuyama; Geert Carmeliet
Journal:  Bonekey Rep       Date:  2014-02-05

Review 3.  Mechanism of Bone Mineralization.

Authors:  Monzur Murshed
Journal:  Cold Spring Harb Perspect Med       Date:  2018-12-03       Impact factor: 6.915

Review 4.  Role of local vitamin D signaling and cellular calcium transport system in bone homeostasis.

Authors:  Ritsuko Masuyama
Journal:  J Bone Miner Metab       Date:  2013-11-09       Impact factor: 2.626

Review 5.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 6.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

7.  Increased FGF-23 levels are linked to ineffective erythropoiesis and impaired bone mineralization in myelodysplastic syndromes.

Authors:  Heike Weidner; Ulrike Baschant; Franziska Lademann; Maria G Ledesma Colunga; Ekaterina Balaian; Christine Hofbauer; Barbara M Misof; Paul Roschger; Stéphane Blouin; William G Richards; Uwe Platzbecker; Lorenz C Hofbauer; Martina Rauner
Journal:  JCI Insight       Date:  2020-08-06

8.  Prevention of the disrupted enamel phenotype in Slc4a4-null mice using explant organ culture maintained in a living host kidney capsule.

Authors:  Xin Wen; Ira Kurtz; Michael L Paine
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

Review 9.  The Biphasic Effect of Vitamin D on the Musculoskeletal and Cardiovascular System.

Authors:  Armin Zittermann
Journal:  Int J Endocrinol       Date:  2017-08-23       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.